Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

615

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Parkinson Disease
Interventions
DRUG

Mirapex LA

Pramipexole Hydrochloride Hydrate

Trial Locations (118)

Unknown

Boehringer Ingelheim Investigational Site 28, Abiko,Chiba

Boehringer Ingelheim Investigational Site 86, Akashi,Hyogo

Boehringer Ingelheim Investigational Site 13, Akita,Akita

Boehringer Ingelheim Investigational Site 9, Aomori,Aomori

Boehringer Ingelheim Investigational Site 2, Asahikawa,Hokkaido

Boehringer Ingelheim Investigational Site 36, Bunkyo,Tokyo

Boehringer Ingelheim Investigational Site 35, Chuo,Tokyo

Boehringer Ingelheim Investigational Site 40, Chuo,Tokyo

Boehringer Ingelheim Investigational Site 54, Chuo,Yamanashi

Boehringer Ingelheim Investigational Site 6, Date,Hokkaido

Boehringer Ingelheim Investigational Site 34, Edogawa,Tokyo

Boehringer Ingelheim Investigational Site 32, Fuchu,Tokyo

Boehringer Ingelheim Investigational Site 22, Fujioka,Gunma

Boehringer Ingelheim Investigational Site 46, Fujisawa,Kanagawa

Boehringer Ingelheim Investigational Site 48, Fujisawa,Kanagawa

Boehringer Ingelheim Investigational Site 24, Fukaya,Saitama

Boehringer Ingelheim Investigational Site 53, Fukui,Fukui

Boehringer Ingelheim Investigational Site 105, Fukuoka,Fukuoka

Boehringer Ingelheim Investigational Site 106, Fukuoka,Fukuoka

Boehringer Ingelheim Investigational Site 109, Fukuoka,Fukuoka

Boehringer Ingelheim Investigational Site 16, Fukushima,Fukushima

Boehringer Ingelheim Investigational Site 60, Gifu,Gifu

Boehringer Ingelheim Investigational Site 44, Hadano,Kanagawa

Boehringer Ingelheim Investigational Site 62, Hamamatsu,Shizuoka

Boehringer Ingelheim Investigational Site 96, Hiroshima,Hiroshima

Boehringer Ingelheim Investigational Site 97, Hiroshima,Hiroshima

Boehringer Ingelheim Investigational Site 78, Ibaraki,Osaka

Boehringer Ingelheim Investigational Site 29, Ichihara,Chiba

Boehringer Ingelheim Investigational Site 68, Ichinomiya,Aichi

Boehringer Ingelheim Investigational Site 57, Iida,Nagano

Boehringer Ingelheim Investigational Site 108, Iiduka,Fukuoka

Boehringer Ingelheim Investigational Site 88, Ikoma,Nara

Boehringer Ingelheim Investigational Site 103, Imabari,Ehime

Boehringer Ingelheim Investigational Site 17, Iwaki,Fukushima

Boehringer Ingelheim Investigational Site 3, Iwamizawa,Hokkaido

Boehringer Ingelheim Investigational Site 117, Kirishima,Kagoshima

Boehringer Ingelheim Investigational Site 111, Kitakyushu,Fukuoka

Boehringer Ingelheim Investigational Site 5, Kitami,Hokkaido

Boehringer Ingelheim Investigational Site 55, Kofu,Yamanashi

Boehringer Ingelheim Investigational Site 70, Konan,Aichi

Boehringer Ingelheim Investigational Site 27, Koshigaya,Saitama

Boehringer Ingelheim Investigational Site 114, Kumamoto,Kumamoto

Boehringer Ingelheim Investigational Site 107, Kurume,Fukuoka

Boehringer Ingelheim Investigational Site 77, Kyoto,Kyoto

Boehringer Ingelheim Investigational Site 23, Maebashi,Gunma

Boehringer Ingelheim Investigational Site 42, Minato,Tokyo

Boehringer Ingelheim Investigational Site 116, Miyakonojo,Miyazaki

Boehringer Ingelheim Investigational Site 66, Miyoshi,Aichi

Boehringer Ingelheim Investigational Site 10, Morioka,Iwate

Boehringer Ingelheim Investigational Site 74, Moriyama,Shiga

Boehringer Ingelheim Investigational Site 4, Muroran,Hokkaido

Boehringer Ingelheim Investigational Site 56, Nagano,Nagano

Boehringer Ingelheim Investigational Site 30, Nagareyama,Chiba

Boehringer Ingelheim Investigational Site 113, Nagasaki,Nagasaki

Boehringer Ingelheim Investigational Site 65, Nagoya,Aichi

Boehringer Ingelheim Investigational Site 67, Nagoya,Aichi

Boehringer Ingelheim Investigational Site 52, Nanao,Ishikawa

Boehringer Ingelheim Investigational Site 104, Nangoku,Kouchi

Boehringer Ingelheim Investigational Site 50, Niigata,Niigata

Boehringer Ingelheim Investigational Site 85, Nishinomiya,Hyogo

Boehringer Ingelheim Investigational Site 72, Obu,Aichi

Boehringer Ingelheim Investigational Site 61, Ogaki,Gifu

Boehringer Ingelheim Investigational Site 92, Ohta,Shimane

Boehringer Ingelheim Investigational Site 115, Oita,Oita

Boehringer Ingelheim Investigational Site 93, Okayama,Okayama

Boehringer Ingelheim Investigational Site 95, Okayama,Okayama

Boehringer Ingelheim Investigational Site 118, Okinawa,Okinawa

Boehringer Ingelheim Investigational Site 110, Onojo,Fukuoka

Boehringer Ingelheim Investigational Site 80, Osaka,Osaka

Boehringer Ingelheim Investigational Site 81, Osaka,Osaka

Boehringer Ingelheim Investigational Site 82, Osaka,Osaka

Boehringer Ingelheim Investigational Site 38, Ota,Tokyo

Boehringer Ingelheim Investigational Site 75, Otsu,Shiga

Boehringer Ingelheim Investigational Site 76, Otsu,Shiga

Boehringer Ingelheim Investigational Site 18, Ryugasaki,Ibaragi

Boehringer Ingelheim Investigational Site 43, Sagamihara,Kanagawa

Boehringer Ingelheim Investigational Site 47, Sagamihara,Kanagawa

Boehringer Ingelheim Investigational Site 25, Saitama,Saitama

Boehringer Ingelheim Investigational Site 26, Saitama,Saitama

Boehringer Ingelheim Investigational Site 79, Sakai,Osaka

Boehringer Ingelheim Investigational Site 83, Sakai,Osaka

Boehringer Ingelheim Investigational Site 102, Sakaide,Kagawa

Boehringer Ingelheim Investigational Site 58, Saku,Nagano

Boehringer Ingelheim Investigational Site 31, Sakura,Chiba

Boehringer Ingelheim Investigational Site 98, Sanyōonoda

Boehringer Ingelheim Investigational Site 1, Sapporo,Hokkaido

Boehringer Ingelheim Investigational Site 7, Sapporo,Hokkaido

Boehringer Ingelheim Investigational Site 8, Sapporo,Hokkaido

Boehringer Ingelheim Investigational Site 59, Sekigahara,Gifu

Boehringer Ingelheim Investigational Site 11, Sendai,Miyagi

Boehringer Ingelheim Investigational Site 12, Sendai,Miyagi

Boehringer Ingelheim Investigational Site 33, Setagaya,Tokyo

Boehringer Ingelheim Investigational Site 69, Seto,Aichi

Boehringer Ingelheim Investigational Site 63, Shimoda,Shizuoka

Boehringer Ingelheim Investigational Site 64, Shimoda,Shizuoka

Boehringer Ingelheim Investigational Site 99, Shimonoseki,Yamaguchi

Boehringer Ingelheim Investigational Site 20, Shimotsuke,Tochigi

Boehringer Ingelheim Investigational Site 21, Shimotsuke,Tochigi

Boehringer Ingelheim Investigational Site 90, Shingu,Wakayama

Boehringer Ingelheim Investigational Site 37, Shinjuku,Tokyo

Boehringer Ingelheim Investigational Site 39, Shinjuku,Tokyo

Boehringer Ingelheim Investigational Site 41, Shinjuku,Tokyo

Boehringer Ingelheim Investigational Site 51, Takaoka,Toyama

Boehringer Ingelheim Investigational Site 101, Tokushima,Tokushima

Boehringer Ingelheim Investigational Site 112, Tosu,Saga

Boehringer Ingelheim Investigational Site 71, Toyokawa,Aichi

Boehringer Ingelheim Investigational Site 84, Toyonaka,Osaka

Boehringer Ingelheim Investigational Site 87, Toyooka,Hyogo

Boehringer Ingelheim Investigational Site 73, Tsu,Mie

Boehringer Ingelheim Investigational Site 19, Tsukuba,Ibaragi

Boehringer Ingelheim Investigational Site 94, Tsukubo,Okayama

Boehringer Ingelheim Investigational Site 15, Tsuruoka,Yamagata

Boehringer Ingelheim Investigational Site 89, Wakayama,Wakayama

Boehringer Ingelheim Investigational Site 91, Yazu,Tottori

Boehringer Ingelheim Investigational Site 45, Yokohama,Kanagawa

Boehringer Ingelheim Investigational Site 49, Yokohama,Kanagawa

Boehringer Ingelheim Investigational Site 14, Yokote,Akita

Boehringer Ingelheim Investigational Site 100, Yoshinogawa,Tokushima

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01525641 - Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's Disease | Biotech Hunter | Biotech Hunter